In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy

Growing in vitro evidence suggests NHE-1, a known target for reactive oxygen species (ROS), as a key mediator in cardiac hypertrophy (CH). Moreover, NHE-1 inhibition was shown effective in preventing CH and failure; so has been the case for AT1 receptor (AT1R) blockers. Previous experiments indicate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cingolani, Oscar H., Pérez, Néstor Gustavo, Ennis, Irene Lucía, Álvarez, María C., Mosca, Susana María, Schinella, Guillermo Raúl, Escudero, Eduardo Manuel, Console-Avegliano, Gloria Miriam, Cingolani, Horacio Eugenio
Formato: Articulo
Lenguaje:Inglés
Publicado: 2011
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/132661
Aporte de:
id I19-R120-10915-132661
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Medicina
Hypertrophy
Sodium–hydrogen exchange
Oxidative stress
Angiotensin
Phosphorylation
spellingShingle Medicina
Hypertrophy
Sodium–hydrogen exchange
Oxidative stress
Angiotensin
Phosphorylation
Cingolani, Oscar H.
Pérez, Néstor Gustavo
Ennis, Irene Lucía
Álvarez, María C.
Mosca, Susana María
Schinella, Guillermo Raúl
Escudero, Eduardo Manuel
Console-Avegliano, Gloria Miriam
Cingolani, Horacio Eugenio
In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy
topic_facet Medicina
Hypertrophy
Sodium–hydrogen exchange
Oxidative stress
Angiotensin
Phosphorylation
description Growing in vitro evidence suggests NHE-1, a known target for reactive oxygen species (ROS), as a key mediator in cardiac hypertrophy (CH). Moreover, NHE-1 inhibition was shown effective in preventing CH and failure; so has been the case for AT1 receptor (AT1R) blockers. Previous experiments indicate that myocardial stretch promotes angiotensin II release and post-translational NHE-1 activation; however, in vivo data supporting this mechanism and its long-term consequences are scanty. In this work, we thought of providing in vivo evidence linking AT1R with ROS and NHE-1 activation in mediating CH. CH was induced in mice by TAC. A group of animals was treated with the AT1R blocker losartan. Cardiac contractility was assessed by echocardiography and pressure–volume loop hemodynamics. After 7 weeks, TAC increased left ventricular (LV) mass by ~45% vs. sham and deteriorated LV systolic function. CH was accompanied by activation of the redox-sensitive kinase p90<sup>RSK</sup> with the consequent increase in NHE-1 phosphorylation. Losartan prevented p90<sup>RSK</sup> and NHE-1 phosphorylation, ameliorated CH and restored cardiac function despite decreased LV wall thickness and similar LV systolic pressures and diastolic dimensions (increased LV wall stress). In conclusion, AT1R blockade prevented excessive oxidative stress, p90<sup>RSK</sup> and NHE-1 phosphorylation, and decreased CH independently of hemodynamic changes. In addition, cardiac performance improved despite a higher work load.
format Articulo
Articulo
author Cingolani, Oscar H.
Pérez, Néstor Gustavo
Ennis, Irene Lucía
Álvarez, María C.
Mosca, Susana María
Schinella, Guillermo Raúl
Escudero, Eduardo Manuel
Console-Avegliano, Gloria Miriam
Cingolani, Horacio Eugenio
author_facet Cingolani, Oscar H.
Pérez, Néstor Gustavo
Ennis, Irene Lucía
Álvarez, María C.
Mosca, Susana María
Schinella, Guillermo Raúl
Escudero, Eduardo Manuel
Console-Avegliano, Gloria Miriam
Cingolani, Horacio Eugenio
author_sort Cingolani, Oscar H.
title In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy
title_short In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy
title_full In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy
title_fullStr In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy
title_full_unstemmed In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy
title_sort in vivo key role of reactive oxygen species and nhe-1 activation in determining excessive cardiac hypertrophy
publishDate 2011
url http://sedici.unlp.edu.ar/handle/10915/132661
work_keys_str_mv AT cingolanioscarh invivokeyroleofreactiveoxygenspeciesandnhe1activationindeterminingexcessivecardiachypertrophy
AT pereznestorgustavo invivokeyroleofreactiveoxygenspeciesandnhe1activationindeterminingexcessivecardiachypertrophy
AT ennisirenelucia invivokeyroleofreactiveoxygenspeciesandnhe1activationindeterminingexcessivecardiachypertrophy
AT alvarezmariac invivokeyroleofreactiveoxygenspeciesandnhe1activationindeterminingexcessivecardiachypertrophy
AT moscasusanamaria invivokeyroleofreactiveoxygenspeciesandnhe1activationindeterminingexcessivecardiachypertrophy
AT schinellaguillermoraul invivokeyroleofreactiveoxygenspeciesandnhe1activationindeterminingexcessivecardiachypertrophy
AT escuderoeduardomanuel invivokeyroleofreactiveoxygenspeciesandnhe1activationindeterminingexcessivecardiachypertrophy
AT consoleaveglianogloriamiriam invivokeyroleofreactiveoxygenspeciesandnhe1activationindeterminingexcessivecardiachypertrophy
AT cingolanihoracioeugenio invivokeyroleofreactiveoxygenspeciesandnhe1activationindeterminingexcessivecardiachypertrophy
bdutipo_str Repositorios
_version_ 1764820454210535424